It has been reported that selective cox-2 inhibition can treat hypertension through improving vascular diastole and reducing inflammation and oxidative stress (Chenevard et al., 2003; Hermann et al., 2003; Solomon et al., 2004; Martelli et al., 2013). The gene discussed is PTGS2; the disease is hypertensive disorder.